What are the Global Market Size and Growth Projections for Liver Diseases Therapeutics?
The liver diseases therapeutics market size has seen sturdy growth in recent years, moving from $14.16 billion in 2024 to $15.23 billion in 2025, a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to high prevalence of liver diseases, alcohol consumption patterns, advancements in diagnostics, obesity and metabolic syndrome, awareness and screening programs, government initiatives for hepatitis control.
Notably, the market is projected to witness strong growth in the coming years, expected to reach $20.78 billion in 2029 at a CAGR of 8.1%. Incremental growth is anticipated, courtesy to precision medicine approaches, innovations in RNA therapeutics, focus on fibrosis treatments, patient advocacy and support groups, and regulatory support for orphan drugs. Major trends dominating the forecast period include advancements in treatment for hepatitis C, emergence of novel therapies for liver fibrosis, exploration of immunotherapies and shift towards telemedicine and remote monitoring.
Get Your Free Sample of The Global Liver Diseases Therapeutics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7969&type=smp
What are the Key Growth Drivers of the Liver Diseases Therapeutics Market?
The growth in liver disease therapeutics market is primarily driven by the rising prevalence of liver diseases. Liver disease essentially refers to any condition affecting the liver, with effective therapeutics in place to help with its treatment. For instance, by April 2024, as per the Office for Health Improvement and Disparities, a UK-based government department, the mortality rate from liver disease in individuals below 75 years in England had jumped to 21.4 per 100,000 population, with males accounting for 6,664 premature deaths compared to 3,929 for females.
Noteworthy Market Segments in the Liver Diseases Therapeutics Industry:
Liver diseases therapeutics market is segmented by:
1) Disease Type: Hepatitis, Non-Alcoholic Fatty Liver Disease, Alcohol-Induced, Liver Cancer
2) Treatment: Antiviral, Vaccines, Chemotherapy, Immunosuppressive Agents, Corticosteroids
3) End User: Hospitals, Ambulatory Surgery Centers, Other End Users
Order your report now for swift delivery:
https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report
Which Companies Dominate the Liver Diseases Therapeutics Market?
Some of the leading companies operating in the liver diseases therapeutics market are Astellas Pharma Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, Merck & Co. Inc., Novartis AG, GlaxoSmithKline PLC, Abbott Laboratories Inc., Pfizer Inc., Sanofi SA, Johnson & Johnson Services Inc., Bayer AG, AbbVie Inc., and Takeda Pharmaceutical Company Limited among others.
What Trends are Shaping the Liver Diseases Therapeutics Market?
Strategic partnerships are an emerging trend gaining traction in the liver disease therapeutics market. In order to strengthen their market dominance, major companies are often observed to undertake collaborations. For example, Aligos Therapeutics Inc., a US-based clinical-stage biopharmaceutical company, announced a collaboration with liver disease therapeutics giant Merck & Co in January 2022, to discover and develop oligonucleotide therapies for non-alcoholic steatohepatitis.
Which Regions are Witnessing Rapid Growth in the Liver Diseases Therapeutics Market?
In 2024, North America held the biggest share in the liver diseases therapeutics market, while the Asia-Pacific region is expected to register the fastest growth during the forecast period. The liver diseases therapeutics market report also covers other regions like Western Europe, Eastern Europe, South America, Middle East, and Africa.
What Does The Liver Diseases Therapeutics Market Report 2025 Offer?
Liver disease therapeutics refers to the treatment of several types of liver ailments, diseases caused by viruses, including hepatitis A, B, and C. Liver disease therapeutics are critical in enhancing the quality of life for those affected by liver conditions and relieving the overall strain of liver disease on healthcare systems. The Liver Diseases Therapeutics Market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7969
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
